Makary to senators: FDA staff cuts won't delay user fee targets

FDA Commissioner Marty Makary defended thousands of staff cuts during his first congressional hearing since taking office, seeking to reassure senators that review timelines for new drugs and devices won’t be delayed. "The agency doubled ...